GlassScriptPhysician profile
Dennis Hurwitz
NPI 1598847741
$17,657.53
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,112 · 2020: $456 · 2021: $700 · 2022: $15K · 2023: $231 · 2024: $17.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $249.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $248.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lumenis Be LTD | $15,000.00 | 2022 | |
| Sientra, INC. | $1,552.97 | 2019-2021 | |
| Tepha INC | $213.25 | 2019 | |
| Mentor Worldwide LLC | $151.04 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer |
| Galderma Laboratories, L.P. | $150.00 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $145.37 | 2019-2022 | |
| Heron Therapeutics, INC. | $99.64 | 2023 | Zynrelef |
| Merz North America, INC. | $86.36 | 2019-2023 | Xeomin |
| Allergan, INC. | $57.92 | 2020-2022 | |
| Acelrx Pharmaceuticals, INC. | $51.91 | 2021-2022 | |
| Integra Lifesciences Corporation | $41.83 | 2022 | |
| Abbvie INC. | $30.67 | 2023 | |
| Ardelyx, INC. | $23.86 | 2023 | Ibsrela |
| Pacira Pharmaceuticals Incorporated | $19.50 | 2019 | |
| Hydrofera LLC | $17.80 | 2024 | Hydrofera Blue |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $15.41 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Hurwitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.